Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KDM5A | P29375 | 1/20 | 0.49 |
| ▸ | KDM5C | P41229 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22215821 | 0.96 | SMN1; SMN2 (0.55) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL14176619 | 0.89 | KDM4E (0.50) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL1159573 | 0.88 | KDM4E (0.49) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL29340145 | 0.88 | HSD17B10 (0.52) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL19604880 | 0.86 | SMN1; SMN2 (0.58) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL3468787 | 0.86 | KDM4E (0.56) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL1628363 | 0.85 | TSHR (0.50) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL19604879 | 0.85 | LMNA (0.56) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL14172740 | 0.85 | KDM4E (0.60) | SMN1; SMN2KDM4EPOLBLMNANPC1 | |
| SCHEMBL668774 | 0.82 | SMN1; SMN2 (0.58) | SMN1; SMN2KDM4EPOLBLMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104230681-A | Preparation method of 1,2,3-trimethoxy-5-allylbenzene | CHENG WENFENG | 2014-12-24 | — | — | CN | claimed |
| EP-4640794-A1 | METHOD FOR PREPARING JET FUEL FROM LIGNIN OIL | TotalEnergies OneTech (FR) | 2025-10-29 | — | — | EP | disclosed |
| US-20250085264-A1 | METHOD AND DEVICE FOR IMPROVING THE QUALITY AND TRACEABILITY OF ALCOHOLIC BEVERAGES, IN PARTICULAR WINES | M&WINE (FR) | 2025-03-13 | — | — | US | disclosed |
| EP-4457510-A1 | METHOD AND DEVICE FOR IMPROVING THE QUALITY AND TRACEABILITY OF ALCOHOLIC BEVERAGES, IN PARTICULAR WINES | M&Wine (FR) | 2024-11-06 | — | — | EP | disclosed |
| WO-2023126615-A1 | METHOD AND DEVICE FOR IMPROVING THE QUALITY AND TRACEABILITY OF ALCOHOLIC BEVERAGES, IN PARTICULAR WINES | M&WINE (FR) | 2023-07-06 | — | — | WO | disclosed |
| US-10307353-B2 | 1-phenylmono- or -polyhydroxypropane compounds, compositions and cosmetic uses thereof | L'OREAL (FR) | 2019-06-04 | — | — | US | disclosed |
| US-20170360665-A1 | NOVEL 1-PHENYLMONO- OR -POLYHYDROXYPROPANE COMPOUNDS, COMPOSITIONS AND COSMETIC USES THEREOF | L'OREAL (FR) | 2017-12-21 | — | — | US | disclosed |
| US-20170360665-A1 | NOVEL 1-PHENYLMONO- OR -POLYHYDROXYPROPANE COMPOUNDS, COMPOSITIONS AND COSMETIC USES THEREOF | L'OREAL (FR) | 2017-12-21 | — | — | US | disclosed |
| WO-2016092074-A1 | NOVEL 1-PHENYLMONO- OR -POLYHYDROXYPROPANE COMPOUNDS, COMPOSITIONS AND COSMETIC USES THEREOF | L'OREAL (FR) | 2016-06-16 | — | — | WO | disclosed |
| CN-104230681-A | Preparation method of 1,2,3-trimethoxy-5-allylbenzene | CHENG WENFENG | 2014-12-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10307353-B2 | 1-phenylmono- or -polyhydroxypropane compounds, compositions and cosmetic uses thereof | GLA, PAH, P4HA1 | SMN1; SMN2 4060/4885KDM4E 772/4885POLB 548/4885 |
| US-20170360665-A1 | NOVEL 1-PHENYLMONO- OR -POLYHYDROXYPROPANE COMPOUNDS, COMPOSITIONS AND COSMETIC USES THEREOF | GLA, PAH, P4HA1 | SMN1; SMN2 4265/4885KDM4E 762/4885POLB 661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.